Feb 20, 2025 07:02PM
Jan 21, 2025 08:00AM
Jan 13, 2025 08:00AM
Dec 4, 2024 08:00AM
Nov 13, 2024 06:30AM
Aug 6, 2024 04:01PM
Jun 28, 2024 06:30AM ARS Pharmaceuticals (SPRY) Announces EURneffy Recommended for Approval by CHMP
Jun 28, 2024 06:30AM
Jun 28, 2024 06:30AM
May 9, 2024 04:05PM
Apr 3, 2024 09:01AM
Apr 3, 2024 09:01AM
Mar 21, 2024 04:05PM
Mar 7, 2024 04:05PM ARS Pharmaceuticals Reviews Recent Clinical Updates and Commercial Opportunity at neffy® Investor Day
Feb 20, 2024 09:03AM
Feb 20, 2024 09:01AM
Feb 5, 2024 09:01AM
Aug 10, 2023 04:00PM
Jun 20, 2023 08:00AM
Jun 20, 2023 08:00AM
May 15, 2023 09:00AM ARS Pharmaceuticals Highlights Progress and Reports First Quarter 2023 Financial Results
May 15, 2023 09:00AM
May 12, 2023 05:40AM
May 11, 2023 07:01PM
May 9, 2023 09:12AM
May 9, 2023 09:10AM
Mar 28, 2023 09:40AM
Mar 28, 2023 09:39AM ARS Pharmaceuticals Announces FDA Advisory Committee for neffy® for the Treatment of Allergic Reactions (Type 1), Including Anaphylaxis
Mar 28, 2023 09:39AM
Mar 23, 2023 04:01PM
Mar 23, 2023 04:01PM
Nov 10, 2022 08:02AM
Nov 10, 2022 08:00AM
Nov 10, 2022 08:00AM
Nov 8, 2022 04:04PM ARS Pharmaceuticals (SPRY) Closes Merger with Silverback Therapeutics (SBTX)
Nov 8, 2022 04:02PM
Nov 8, 2022 04:02PM

15,423 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All